Hereditary neuropathy with liability to pressure palsies: Association with central nervous system demyelination

Muscle and Nerve

Volumn 19, Issue 6, 1996, Pages 770-773

  Amato, Anthony A ^a,c   Barohn, Richard J ^b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Building 3611   (United States)

Author keywords

central nervous system abnormalities (demyelination); hereditary neuropathy with liability to pressure palsies; mutations; peripheral myelin protein 22; tomaculous neuropathy

Indexed keywords

DNA;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME DELETION; DEMYELINATION; DISEASE ASSOCIATION; GEL ELECTROPHORESIS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MALE; MUSCLE ACTION POTENTIAL; MUTATION; MYOTATIC REFLEX; NERVE BIOPSY; NERVE CONDUCTION; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARALYSIS; PRIORITY JOURNAL;

ADULT; BRAIN; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 14; HEREDITARY MOTOR AND SENSORY NEUROPATHIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDIAN NERVE; NEURAL CONDUCTION; PERONEAL NERVE; RADIAL NERVE; SURAL NERVE; TIBIAL NERVE; ULNAR NERVE;

EID: 0029920983     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199606)19:6<770::AID-MUS13>3.0.CO;2-P     Document Type: Article

References (22)

1. Amato AA, Gronseth GS, Callerame KJ, Kagan-Hallet KS, Bryan WW, Barohn RJ: Tomaculous neuropathy: a clinical and electrophysiological study in patients with and without 1.5-Mb deletions in chromosome 17p11.2. Muscle Nerve 1996;1:16-22.
2. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR: Chronic inflammatory polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989;46:878-884.
3. Behse F, Buchthal F, Carlsen F, Knappeis GG: Hereditary neuropathy with liability to pressure palsies. Electrophysiological and histopathological aspects. Brain 1972;95:777-794.
4. Bird TD, Griep E. Pattern reversal visual evoked potentials. Studies in Charcot-Marie-Tooth hereditary neuropathy. Arch Neurol 1981;38:739-741.
5. Chance P, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, Swanson PD, Odelberg SJ, Disteche CM, Bird TD: DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993;72:143-151.
6. Joy JL, Oh SJ: Tomaculous neuropathy presenting as acute recurrent polyneuropathy. Ann Neurol 1989;26:98-100.
7. Jones SJ, Carrol WM, Halliday AM: Peripheral and central sensory nerve conduction in Charcot-Marie-Tooth disease and comparison with Friedreich's ataxia. J Neurol Sci 1983; 61:135-148.
8. Kaku DA, England JD, Sumner AJ: Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 1994;17:941-947.
9. Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA: Uniform slowing of conduction velocities in Charcot-Marie-Tooth polyneuropathy type 1. Neurology 1993;43:2664-2667.
10. Lupski JR, Chance PF, Garcia CA: Inherited primary peripheral neuropathies. Molecular genetics and clinical implications of CMT 1A and HNPP. JAMA 1993;270:2326-2330.
11. Madrid R, Bradley WG: The pathology of neuropathies with focal thickening of the myelin sheath (tomaculous neuropathy). Studies on the formation of the abnormal myelin sheath. J Neurol Sci 1975;25:415-448.
12. Malandrini A, Guazzi GC, Federico A: Sensory-motor polyneuropathy in two siblings: atypical presentation of tomaculous neuropathy. Clin Neuropathol 1992;11:318-322.
13. Mariman ECM, Gabreëls-Festen AAWM, van Beersum SEC, Valentijn LJ, Baas F, Bolhuis PA, Jongen PJH, Ropers HH, Gabreëls FJM: Prevalence of the 1.5-Mb 17p deletion in families with hereditary neuropathy with liability to pressure palsies. Ann Neurol 1994;36:650-655.
14. McLeod JG, Low PA, Morgan JA: Charcot-Marie-Tooth disease with Leber optic atrophy. Neurology 1978;28:179-184.
15. Mendell JR, Kolkin S, Kissel JT, Weiss KL, Chakeres DW, Rammohan KW: Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculo-neuropathy. Neurology 1987;37:1291-1294.
16. Nicholsen GA, Velentijn LJ, Cherryson AK, Kennerson ML, Bragg TL, DeKroon RM, Ross DA, Pollard JD, McLeod JG, Bolhuis PA, Baas F: A frame shift mutation in the PMP 22 gene in hereditary neuropathy with liability to pressure palsies. Nature Genet 1994;6:263-266.
17. Simmons Z, Albers JW, Bromberg MB, Feldman EL: Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyneuropaihy: comparison of patients without and with monoclonal gammopathy. Naurology 1993;43:2202-2209.
18. Snipes GJ, Suter U, Welcher AA, Shooter EM: Characterization of a novel peripheral nervous system protein (PMP-22/SR13). J Cell Biol 1992;117:225-238.
19. Tackmann W, Radu EW: Pattern shift visual evoked potentials in Charcot-Marie-Tooth disease, HMSN type 1. J Neurol 1980;224:71-74.
20. Thomas PK, Walker RWH, Rudge P, Morgan-Hughes JA, King RHM, Jacobs JM, Mills KR, Ormerod IEC, Murray NMF, McDonald WI: Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain 1987;110:53-76.
21. Trojaborg W, Hays AP, Latov N, Younger DS: Conduction variables in different types of sensorimotor polyneuropathy with special reference to myelin-associated glycoprotein [abstract ]. Ann Neurol 1994;36:320.
22. Verhagen WIM, Gabreëls-Festen AAWM, van Wensen PJM, Joosten EMG, Vingerhoets HM, Gabreëls FJM, deGraaf R: Hereditary neuropathy with liability to pressure palsies: a clinical, electrophysiological, and morphological study. J Neurol Sci 1993;116:176-184.